Pacific Edge Limited (PFGTF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 23.9 Million NZD | 21.88% |
| 2023 | 19.61 Million NZD | 54.7% |
| 2022 | 7.93 Million NZD | 47.1% |
| 2021 | 5.39 Million NZD | 108.18% |
| 2020 | 2.59 Million NZD | -32.13% |
| 2019 | 3.81 Million USD | 12.26% |
| 2018 | 3.4 Million USD | 5.99% |
| 2017 | 3.2 Million USD | -7.14% |
| 2016 | 3.45 Million USD | 37.79% |
| 2015 | 2.5 Million NZD | 452.0% |
| 2014 | 454.18 Thousand NZD | 197.81% |
| 2013 | 152.5 Thousand NZD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 4.28 Million USD | -36.04% |
| 2024 Q2 | 4.18 Million USD | 87.69% |
| 2024 FY | 23.9 Million NZD | 94.78% |
| 2024 Q4 | 3.37 Million USD | 0.0% |
| 2024 Q3 | 3.56 Million USD | -56.95% |
| 2023 FY | 12.27 Million NZD | 54.7% |
| 2023 Q4 | 3.61 Million USD | -1.5% |
| 2023 Q3 | 3.67 Million USD | 38.65% |
| 2023 Q2 | 2.64 Million USD | 0.0% |
| 2022 FY | 7.93 Million NZD | 47.1% |
| 2022 Q2 | 3.71 Million USD | 0.0% |
| 2022 Q4 | 4.2 Million USD | 0.0% |
| 2021 Q2 | 2.19 Million USD | 0.0% |
| 2021 FY | 5.39 Million NZD | 108.18% |
| 2021 Q4 | 3.06 Million USD | 0.0% |
| 2020 Q2 | 1.43 Million USD | 0.0% |
| 2020 Q4 | 1.23 Million USD | 0.0% |
| 2020 FY | 2.59 Million NZD | -32.13% |
| 2019 FY | 3.81 Million USD | 12.26% |
| 2018 FY | 3.4 Million USD | 5.99% |
| 2017 FY | 3.2 Million USD | -7.14% |
| 2016 FY | 3.45 Million USD | 37.79% |
| 2015 FY | 2.5 Million NZD | 452.0% |
| 2014 FY | 454.18 Thousand NZD | 197.81% |
| 2013 FY | 152.5 Thousand NZD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -2518.51% |
| Arrayit Corporation | 4.37 Million USD | -446.159% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | 7.545% |
| Bioqual, Inc. | 58.59 Million USD | 59.197% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | -56.296% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.676% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | -275.529% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -2173.415% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 40.551% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -5242.358% |
| InVitro International | 792.62 Thousand USD | -2916.169% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | -114.779% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | -230.928% |
| NovelStem International Corp. | 12 Thousand USD | -199125.0% |
| Optigenex Inc. | 465.97 Thousand USD | -5030.588% |
| PharmChem, Inc. | 6.01 Million USD | -297.628% |
| Proteome Sciences plc | 6.4 Million USD | -273.509% |
| Response Genetics, Inc | 18.04 Million USD | -32.522% |
| Rennova Health, Inc. | 13.03 Million USD | -83.39% |
| RushNet, Inc. | 1.78 Million USD | -1237.17% |
| ScreenPro Security Inc. | 1.91 Million USD | -1148.992% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | -529.948% |
| Todos Medical Ltd. | 7.69 Million USD | -210.682% |